中枢神经系统
神经科学
再生(生物学)
神经生长因子
脊髓
神经营养素
神经系统
神经干细胞
脊髓损伤
医学
生物
干细胞
内科学
细胞生物学
受体
作者
Duo Xu,Di Wu,Meng Qin,Lina R. Nih,Chaoyong Liu,Zijun Cao,Jie Ren,Xiangjun Chen,Zhanlong He,Yu Wang,Jiaoqiong Guan,Suqin Duan,Fang Liu,Xiangsheng Liu,Jesse Li,Dushawn Harley,Bin Xu,Lei Hou,Irvin S. Y. Chen,Jing Wen,Wei Chen,Sina Pourtaheri,Yunfeng Lu
标识
DOI:10.1002/adma.201900727
摘要
Abstract The central nervous system (CNS) plays a central role in the control of sensory and motor functions, and the disruption of its barriers can result in severe and debilitating neurological disorders. Neurotrophins are promising therapeutic agents for neural regeneration in the damaged CNS. However, their penetration across the blood–brain barrier remains a formidable challenge, representing a bottleneck for brain and spinal cord therapy. Herein, a nanocapsule‐based delivery system is reported that enables intravenously injected nerve growth factor (NGF) to enter the CNS in healthy mice and nonhuman primates. Under pathological conditions, the delivery of NGF enables neural regeneration, tissue remodeling, and functional recovery in mice with spinal cord injury. This technology can be utilized to deliver other neurotrophins and growth factors to the CNS, opening a new avenue for tissue engineering and the treatment of CNS disorders and neurodegenerative diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI